blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0117171

EP0117171 - Amino derivatives of substituted pyridazines, process for their preparation and medicines containing them [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.05.1988
Database last updated on 15.06.2024
Most recent event   Tooltip17.05.1988No opposition filed within time limitpublished on 06.07.1988 [1988/27]
Applicant(s)For all designated states
SANOFI S.A.
40, Avenue George V
75008 Paris / FR
[N/P]
Former [1984/35]For all designated states
SANOFI S.A.
40, Avenue George V
F-75008 Paris / FR
Inventor(s)01 / Kan, Jean-Paul
25 Lotissement l'Olivette
F-34100 Clapiers / FR
02 / Biziere, Kathleen
6, Lotissement Rayons d'Oc
F-34170 Clapiers / FR
03 / Wermuth, Camille-Georges
3, rue de la Côte d'Azur
F-67100 Strasbourg / FR
[1984/35]
Representative(s)Gillard, Marie-Louise, et al
Cabinet Beau de Loménie 158, rue de l'Université
75340 Paris Cédex 07 / FR
[N/P]
Former [1984/35]Gillard, Marie-Louise, et al
Cabinet Beau de Loménie 158, rue de l'Université
F-75340 Paris Cédex 07 / FR
Application number, filing date84400102.418.01.1984
[1984/35]
Priority number, dateFR1983000102924.01.1983         Original published format: FR 8301029
[1984/35]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report 
No.:EP0117171
Date:29.08.1984
Language:FR
[1984/35]
Type: B1 Patent specification 
No.:EP0117171
Date:01.07.1987
Language:FR
[1987/27]
Search report(s)(Supplementary) European search report - dispatched on:EP19.06.1984
ClassificationIPC:C07D237/20, C07D409/04
[1984/35]
CPC:
C07D409/04 (EP,US); C07D413/12 (KR); A61P25/00 (EP);
A61P25/02 (EP); A61P25/24 (EP); A61P25/26 (EP);
C07D237/20 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   FR,   GB,   IT,   LI,   LU,   NL,   SE [1984/35]
TitleGerman:Aminoderivate von in Stellung 6 durch ein heterocyclisch oder ein alicyclisch substituiertes Pyridazin, Verfahren zu deren Herstellung und Heilmittel die sie enthalten[1984/35]
English:Amino derivatives of substituted pyridazines, process for their preparation and medicines containing them[1984/35]
French:Dérivés aminés de la pyridazine substitués en position 6 par un hétérocycle ou un alicycle, procédé d'obtention et médicaments les contenant[1984/35]
Examination procedure27.12.1984Examination requested  [1985/11]
06.11.1985Despatch of a communication from the examining division (Time limit: M02)
30.12.1985Reply to a communication from the examining division
09.05.1986Despatch of communication of intention to grant (Approval: )
08.01.1987Communication of intention to grant the patent
16.03.1987Fee for grant paid
16.03.1987Fee for publishing/printing paid
Opposition(s)06.04.1988No opposition filed within time limit [1988/27]
Fees paidRenewal fee
18.01.1986Renewal fee patent year 03
17.01.1987Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]FR2141697  (CEPBEPE)
 [Y]  - CHEMICAL ABSTRACTS, vol. 76, no. 7, 14 février 1972, page 22, no. 41974h, Columbus, Ohio, US
 [Y]  - CHEMICAL ABSTRACTS, vol. 73, no. 1, 6 juillet 1970, page 199, no. 12845z, Columbus, Ohio, US
Examination   - CHEMICAL ABSTRACTS, vol. 76, no. 7, 14 février 1972, page 22, no. 41974h, Columbus, Ohio, US M.R. ORNELLAS: "Biochemical studies of cerebral subfractions after chronic administration of 4-methyl-3 (2-(morpholino)ethylamino)-6-phenylpyridazine hydrochloride, AG620"
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.